NCT00508924 / 2004-001674-80: Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Intervention (PCI) |
|
|
| Completed | 2 | 140 | Europe | Argatroban, Heparin | Mitsubishi Tanabe Pharma Corporation | Coronary Artery Disease, Angina, Unstable | | 10/06 | | |
| Completed | 2 | 36 | US | Intravenous Glycoprotein inhibitor + ASA, Clopidogrel, Cangrelor, Abciximab, Eptifibatide, Tirofiban, Antiplatelet Therapy (ASA, Clopidogrel), Thienopyridines, Ticlopidine, Clopidogrel, Prasugrel | Icahn School of Medicine at Mount Sinai | Stable Angina | 06/09 | 06/09 | | |